Ovarian Tissue Current Events | Ovarian Tissue News | 5
|
| Page
5 of
32 |
636 Results |
|
|
|
Sort By:
Page Views | Date |
Scientists take next step in understanding potential target for Ovarian cancer treatment
A traffic cop protein in the cell may have an even more important role: transporting a messenger protein that tells components in the nucleus to stop cell growth. The discovery of this additional role may lead to diagnostic tools and earlier treatments for ovarian cancer. view more (2007-07-17)
Removal of ovaries decreases risk of certain cancers for women at high-risk
Women with mutations in the BRCA1 or BRCA2 genes can significantly reduce their risk of certain types of cancer by having their ovaries removed. view more (2006-07-12)
St. Joseph's provides tissue processing services to researchers in hopes of finding a cure
A special research program at St. Joseph's Hospital and Medical Center is providing a safe and vital research component to scientists in hopes of finding new treatments and cures for a variety of disorders. view more (2006-11-08)
International Study Suggests Carboplatin Could Be First-line Chemotherapy Drug For Ovarian Cancer
Results of an international study in this week's issue of THE LANCET suggest that the drug carboplatin could become a first-line chemotherapeutic agent for the treatment of ovarian cancer. Carboplatin was found to be less toxic, although it had no overall survival benefit, compared with other drugs assessed in the study. Ovarian cancer is the... view more... (2002-08-14)
Studies to find better ways to preserve human eggs, ovarian tissue under way
The goal is to make human eggs, ovarian tissue, blood vessels, even whole organs available when needed. view more (2007-06-07)
Mayo Clinic reports possible new therapy for patients with platinum-resistant ovarian cancer
Mayo Clinic today reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy. Thirty-three percent of study participants achieved either complete or partial tumor regression from the therapy, which combines flavopiridol and cisplatin. view more (2007-10-24)
Successes in frozen ovarian tissue technology may offer hope to women being treated for cancer
Berlin, Germany: Doctors in Denmark have succeeded in producing a two-cell embryo after ovarian tissue was removed, frozen, and then thawed and replaced two years later. It is believed that this is the first time a European group has succeeded in creating an embryo in this way. Dr Claus Yding Andersen told the 20th annual conference of the... view more... (2004-06-29)
Controversies Regarding Ovarian Cancer Treatments Addressed
Trials have raised questions on the current management and standard of care for advanced ovarian cancer (AOC). These controversies highlight implications for future clinical research and policy-making, as reviewed in an article published in the International Journal of Gynecological Cancer. view more (2004-11-10)
Study provides clues to prevent spread of ovarian cancer
A drug that blocks production of an enzyme that enables ovarian cancer to gain a foothold in a new site can slow the spread of the disease and prolong survival in mice, according to a study by researchers from the University of Chicago Medical Center, but only if the drug is given early in the disease process. view more (2008-03-14)
Intraperitoneal chemotherapy administration prolongs survival for women with advanced ovarian cancer
A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy. view more (2006-01-05)
Genetic testing for breast or ovarian cancer risk may be greatly underutilized
Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds that few women with family histories of these cancers are even discussing genetic testing with their physicians or other health care providers. view more (2009-05-22)
Experimental Drug Boosts Survival in Recurrent Ovarian Cancer Patients
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently. view more (2007-09-28)
Newly discovered gene may predict aggressive ovarian cancer
Johns Hopkins Kimmel Cancer Center researchers have linked alterations in a gene, called Rsf-1, to the most deadly ovarian cancers. view more (2005-09-30)
Image Guided Treatment Helping Women with Tubo Ovarian Abscesses Avoid Unnecessary Surgery
Image guided drainage of tubo ovarian abscesses help women avoid surgery, according to a study performed at Massachusetts General Hospital in Boston, MA. Tubo ovarian abscesses (TOAs) are an infected collection of pus, involving a patient's fallopian tube(s) or ovaries. They can occur in patients with complicated cases of pelvic inflammatory... view more... (2009-04-24)
New study establishes criteria to detect ovarian cancer in asymptomatic postmenopausal women
Reporting on the largest study of its kind today at the Society of Gynecologic Oncologists 37th Annual Meeting on Women's Cancer, researchers presented new criteria for detecting ovarian cancer malignancy in postmenopausal asymptomatic women, 55 to 74 years old. view more (2006-03-27)
Mayo Clinic finds aggressive surgery best option for advanced-stage ovarian cancer patients
Mayo Clinic Cancer Center researchers report aggressive surgical removal of as much cancer as possible throughout the abdomen in ovarian cancer patients is the best option for most women. view more (2006-01-10)
Cranberries may improve chemotherapy for ovarian cancer
Compounds in cranberries may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer, researchers have found in a laboratory study that will be reported today at the 234th national meeting of the American Chemical Society. view more (2007-08-22)
Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers
Recurrent low-grade serous carcinoma, a rare type of ovarian cancer, is less sensitive to chemotherapy and therefore more difficult to treat than more common high-grade ovarian cancers, according to researchers from The University of Texas M. D. Anderson Cancer Center. view more (2008-03-11)
Breast cancer gene increases risk of several cancers in men
A genetic mutation implicated in an increased risk of breast and ovarian cancers also significantly increases the risk of pancreatic and prostate cancers in men, finds research in the Journal of Medical Genetics. view more (2005-09-02)
Mayo Clinic researchers recommend embryo transfer delay for at-risk women
Mayo Clinic researchers have determined a method to achieve the best results for the mother's health and birth of a live baby for women who undergo in vitro fertilization who demonstrate risk of ovarian hyperstimulation syndrome. view more (2006-10-25)
|
|
| Page
5 of
32 |
636 Results |
|
|
|
Sort By:
Page Views | Date |
|
